Patient-derived iPS cells are valuable tools for developing therapeutic drugs and disease modeling. Compared to primary culture, iPSC-derived cells have several advantages: (1) Amenable to genome editing/engineering; (2) Direct control over genetic diversity with the unlimited proliferation potential; (3) iPSC derived from peripheral blood or skin fibroblasts can be differentiated into cell types which are hard to collect directly from the donors.  Our iPSC service team consists of the industry leading experts and a license from the Stem Cell Academy – Japan.  We are proud to provide feeder-free, footprint-free iPS cells with over 95% success rate. 

iXCells Biotech provides custom genome editing in human cells, including cell lines and patient-derived cells. Although genome editing is not applicable in many somatic cell types, our stem cell products and services can be flexibly tailored to your needs by genome editing. To order custom genome editing service, please contact us.

With many years of experience in developing iPSC-derived disease specific cells, we are proud to provide the most comprehensive differentiation services using ESC/iPSC derived from human or animals. Compared to primary culture, iPSC-derived cells have several advantages: (1) Amenable to genetic engineering; (2) Direct control over genetic diversity with the unlimited proliferation potential; (3) iPSC derived from peripheral blood or skin fibroblasts can be differentiated into certain cell types which are hard to collect directly from the donors, such as cardiomyocytes, cortical neurons, skeletal muscle and supporting cells.

Primary cells are isolated directly from fresh tissues without genetic and chemical modifications. All human primary materials are obtained through IRB approved, donor consented protocols and are completely de-identified according to industry standards.  In addition to custom isolation from tissues we are able to provide derivative materials (RNA, genomic DNA, protein lysates and spent media from any cell type in our collection).

Our fresh and cryo-preserved immune cells drive high impact research in Cancer, Aging, and Infectious Disease. iXCells is a industry leading provider of freshly isolated Peripheral Blood Mononuclear Cells (PBMCs), and are proud to now be offering an expanded collection of fresh immune cells including Macrophages (M1 and M2) for customers within the Continental United States.  In addition to our fresh cells we offer an extensive collection of cryo-preserved immune cells (PBMCs, monocytes, T-cells, B-cells and more) worldwide to support your immunology research needs.